Document is current
Any future updates will be listed below
-
Authors
Sakthivelu, Vignesh https://orcid.org/0009-0000-1652-0850
Schmitt, Anna
Odenthal, Franka https://orcid.org/0000-0003-4138-121X
Ndoci, Kristiano https://orcid.org/0000-0002-9896-8196
Touet, Marian https://orcid.org/0009-0004-7875-1880
Shaib, Ali H.
Chihab, Abdulla https://orcid.org/0009-0002-1237-0087
Wani, Gulzar A. https://orcid.org/0000-0003-2380-5816
Nieper, Pascal
Hartmann, Griffin G. https://orcid.org/0000-0001-9213-8995
Pintelon, Isabel
Kisis, Ilmars https://orcid.org/0000-0001-6207-3991
Boecker, Maike https://orcid.org/0009-0008-0595-8599
Eckert, Naja M. https://orcid.org/0009-0007-2888-0280
Ianicelli Caiaffa, Manoela https://orcid.org/0009-0007-0704-0397
Ibruli, Olta
Weber, Julia
Maresch, Roman https://orcid.org/0000-0003-3393-8882
Bebber, Christina M. https://orcid.org/0000-0002-7841-7493
Chitsaz, Ali
Lütz, Anna https://orcid.org/0009-0000-2891-7038
Kim Alves Carpinteiro, Mira
Morris, Kaylee M.
Franchino, Camilla A.
Benz, Jonas
Pérez-Revuelta, Laura
Soriano-Campos, Jorge A.
Huetzen, Maxim A. https://orcid.org/0009-0008-2217-813X
Goergens, Jonas
Jevtic, Milica
Jahn-Kelleter, Hannah M.
Zempel, Hans https://orcid.org/0000-0002-7510-3077
Placzek, Aleksandra
Hennrich, Alexandru A. https://orcid.org/0000-0002-3233-6145
Conzelmann, Karl-Klaus https://orcid.org/0000-0002-8614-3656
Tumbrink, Hannah L.
Hunold, Pascal https://orcid.org/0000-0002-7087-5908
Isensee, Joerg https://orcid.org/0000-0002-3390-0051
Werr, Lisa https://orcid.org/0000-0002-3697-4136
Gaedke, Felix https://orcid.org/0000-0002-7744-4940
Schauss, Astrid https://orcid.org/0000-0002-6658-2192
Minère, Marielle https://orcid.org/0000-0001-7889-9771
Müller, Marie
Fenselau, Henning https://orcid.org/0000-0001-7136-9751
Liu, Yin https://orcid.org/0000-0002-2377-2703
Heimsoeth, Alena
Gülcüler Balta, Gülce S. https://orcid.org/0000-0002-3626-007X
Walczak, Henning
Frezza, Christian https://orcid.org/0000-0002-3293-7397
Jachimowicz, Ron D. https://orcid.org/0000-0001-9522-7061
George, Julie https://orcid.org/0000-0002-4272-3683
Schmiel, Marcel
Brägelmann, Johannes https://orcid.org/0000-0002-1306-2169
Hucho, Tim https://orcid.org/0000-0002-4147-9308
von Karstedt, Silvia https://orcid.org/0000-0002-7816-5919
Peifer, Martin https://orcid.org/0000-0002-5243-5503
Annibaldi, Alessandro
Hänsel-Hertsch, Robert https://orcid.org/0000-0002-2835-4471
Persigehl, Thorsten
Grüll, Holger
Sos, Martin L. https://orcid.org/0000-0002-2868-100X
Reifenberger, Guido
Fischer, Matthias https://orcid.org/0000-0003-1363-1242
Adriaensen, Dirk
Büttner, Reinhard https://orcid.org/0000-0001-8806-4786
Sage, Julien https://orcid.org/0000-0002-8928-9968
Brouns, Inge
Rad, Roland https://orcid.org/0000-0002-6849-9659
Thomas, Roman K. https://orcid.org/0000-0001-9132-4876
Anstötz, Max https://orcid.org/0000-0003-3071-5835
Rizzoli, Silvio O. https://orcid.org/0000-0002-1667-7839
Bergami, Matteo https://orcid.org/0000-0001-5525-5025
Motori, Elisa https://orcid.org/0000-0001-5997-6866
Reinhardt, Hans Christian https://orcid.org/0000-0001-5706-9349
Beleggia, Filippo https://orcid.org/0000-0003-0234-7094
- License Information
-
More Information
Article History
Received: 20 December 2022
Accepted: 18 July 2025
First Online: 10 September 2025
Competing interests
: H.C.R. received consulting and lecture fees from Abbvie, AstraZeneca, Vertex and Merck. H.C.R. received research funding from AstraZeneca and Gilead Pharmaceuticals. H.C.R. is a co-founder of CDL Therapeutics. R.K.T. is a founder of PearlRiver Bio (now part of Centessa), a shareholder of Centessa, a founder and shareholder of Epiphanes and a consultant to PearlRiver Bio and Epiphanes. R.K.T. has received research support from Roche. R.K.T. and J.S. are co-founders and shareholders of DISCO Pharmaceuticals. M.L.S. is a co-founder and was an advisor of PearlRiver Bio (now part of Centessa). M.L.S. received research funding from PearlRiver Bio (now part of Centessa). S.O.R. is a shareholder of NanoTag Biotechnologies. H.W. was a co-founder of Apogenix. J. George is a consultant to DISCO Pharmaceuticals and received honoraria from MSD and Boehringer Ingelheim. J. Brägelmann has received research funding from Bayer and travel grants from Merck and Bicycle Therapeutics. The other authors declare no competing interests.
